MedTech PMA Pipeline Monitor™ ::

By using Revere's proprietary MedTech (Medical Device) database, our analysts are able to provide a comprehensive and accurate calendar of expected approval dates for Pre-Market Approval (PMA) filed Class III devices.

The annual MedTech PMA Pipeline Monitor Report provides actionable information by identifying MedTech companies with expected PMA approvals over the course of the next two years. The report includes detail on each device candidate, including:
  • Tradenames and indications
  • Competitive landscape
  • Analyst estimates
  • Potential market size
  • Approval impact ranking

Because Revere tracks the pipeline of every U.S.-traded Biotech and Pharmaceutical companies, our analysts are able to continuously monitor the regulatory status of all device candidates. This precise view provides original, unbiased, and insightful information that is an indispensable tool for successful MedTech investing.

Sample individual reports: